Cigna Corp Stock: price and directors' dealings · United States · SEC (Form 4)Track the Cigna Corp stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Cigna Corp has recorded 133 public disclosures. Market capitalisation: €74.5bn. The latest transaction was reported on 8 February 2023 (Don). Among the most active insiders: Cordani David. Every trade is free.
Analyst consensus: bullish or bearish? Analysts rate Cigna Corp Buy (bullish), based on 24 analysts. Average price target: US$340.92.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,833 of 29,055 companies
FCF yld 11%
Earn yld 8.0%
EV/EBITDA 8.9x
ROE 17%
Gross mgn 9.0%
Net mgn 2.2%
Debt/EBITDA 2.6x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 February 2023
All Executives133 Thresholds0 Prospectus0 Other0
Declarations 133 total
● Director · Executives · 6 Feb 2023
200 shares 0Common Stock, $.01 Par Value SEC:0001225208-23-001581:0
● Chairman & CEO · Executives · 9 Jan 2023
50,700 shares 0Common Stock, $.01 Par Value SEC:0001225208-23-000595:0
◇ EVP, CHRO · Executives · 16 Dec 2022
3,009 shares @ US$139.22 39.5% of flow Common Stock, $.01 Par Value SEC:0001225208-22-012918:0
◇ Pres., International Markets · Executives · 8 Dec 2022
9,781 shares @ US$197.35 38.0% of flow Common Stock, $.01 Par Value SEC:0001225208-22-012577:0
● Director · Executives · 8 Nov 2022
2,452 shares 0Common Stock, $.01 Par Value SEC:0001225208-22-011589:0
▼ EVP Operations · Executives · 14 Oct 2022
373 shares @ US$300.00 30.0% of flow Common Stock, $.01 Par Value SEC:0001225208-22-011022:0
▼ President & CEO, Evernorth · Executives · 14 Oct 2022
4,000 shares @ US$300.001 48.0% of flow Common Stock, $.01 Par Value SEC:0001225208-22-011021:0
● EVP, CIO · Executives · 14 Sept 2022
902 shares @ US$285.46 43.5% of flow Common Stock, $.01 Par Value SEC:0001225208-22-010384:0
◇ President, U.S. Commercial · Executives · 12 Sept 2022
6,060 shares @ US$139.22 52.8% of flow Common Stock, $.01 Par Value SEC:0001225208-22-010321:0
◆ EVP & Chief Health Officer · Executives · 1 Sept 2022
1,749 shares 0Common Stock, $.01 Par Value SEC:0001225208-22-010083:0
◇ SVP Tax & Chief Acct. Officer · Executives · 9 Aug 2022
7,044 shares @ US$58.73 96.9% of flow Common Stock, $.01 Par Value SEC:0001225208-22-009439:0
▼ EVP Operations · Executives · 9 Aug 2022
374 shares @ US$285.00 27.3% of flow Common Stock, $.01 Par Value SEC:0001225208-22-009440:0
▼ EVP, Strat, Corp Dev/Solutions · Executives · 1 Aug 2022
902 shares @ US$273.98 7.0% of flow Common Stock, $.01 Par Value SEC:0001225208-22-009254:0
◇ Pres., International Markets · Executives · 8 Jul 2022
9,505 shares @ US$149.135 28.8% of flow Common Stock, $.01 Par Value SEC:0001225208-22-008760:0
◇ EVP, Strat, Corp Dev/Solutions · Executives · 7 Jul 2022
5,094 shares @ US$192.02 28.1% of flow Common Stock, $.01 Par Value SEC:0001225208-22-008762:0
◇ President & CEO, Evernorth · Executives · 7 Jul 2022
5,557 shares @ US$120.895 25.8% of flow Common Stock, $.01 Par Value SEC:0001225208-22-008763:0
▼ EVP Operations · Executives · 7 Jul 2022
374 shares @ US$275.00 26.4% of flow Common Stock, $.01 Par Value SEC:0001225208-22-008761:0
◇ Pres., International Markets · Executives · 28 Jun 2022
3,458 shares @ US$139.22 0.0006% mcap 28.5% of flow Common Stock, $.01 Par Value SEC:0001225208-22-008322:0
◇ EVP, General Counsel · Executives · 17 May 2022
5,901 shares @ US$139.22 0.0010% mcap 32.0% of flow Common Stock, $.01 Par Value SEC:0001225208-22-007208:0
◇ Chairman & CEO · Executives · 17 May 2022
45,261 shares @ US$120.895 0.0069% mcap 22.7% of flow Common Stock, $.01 Par Value SEC:0001225208-22-007209:0
◆ Director · Executives · 27 Apr 2022
757 shares 0Common Stock, $.01 Par Value SEC:0001225208-22-006301:0
◆ Director · Executives · 27 Apr 2022
757 shares 0Common Stock, $.01 Par Value SEC:0001225208-22-006306:0
◆ Director · Executives · 27 Apr 2022
757 shares 0Common Stock, $.01 Par Value SEC:0001225208-22-006300:0
◆ Director · Executives · 27 Apr 2022
757 shares 0Common Stock, $.01 Par Value SEC:0001225208-22-006305:0
◆ Director · Executives · 27 Apr 2022
757 shares 0Common Stock, $.01 Par Value SEC:0001225208-22-006307:0
25 of 133 declarations
Load more (108 remaining) 关于 Cigna Corp Cigna Corp,现以 The Cigna Group 运营,是美国领先的医疗保健公司之一,在美国上市并在纽约证券交易所 (NYSE) 交易,股票代码为 CI。该公司总部位于美国康涅狄格州布隆菲尔德。随着时间的推移,Cigna 从一家传统的健康保险公司发展成为一个多元化的管理式医疗保健平台,将保险覆盖与药房、临床和护理服务相结合。
该集团围绕两个核心业务组织:Cigna Healthcare 和 Evernorth Health Services。Cigna Healthcare 提供医疗、牙科、行为健康、与医疗保险相关的、政府、雇主赞助的、个人和国际健康福利。Evernorth Health Services 包含该公司的健康服务平台,包括药房福利管理、专科药房、送药上门、临床支持服务和行为健康解决方案。这种结构赋予 Cigna 独特的竞争优势,因为它既能获得基于保费的保险收入,又能获得基于服务的医疗保健收入,同时还有助于该集团更积极地管理医疗成本趋势。
从投资者的角度来看,Cigna 的吸引力在于其平台的广度、客户关系的持续性以及其将福利管理与护理服务相结合的能力。其产品组合包括医疗计划、药房解决方案、牙科和视力保险、行为健康计划、健康工具、成本管理计划和数字健康服务。该公司服务于雇主、政府项目、消费者、经纪人、顾问和医疗保健提供商,在美国和选定的国际市场拥有广泛的业务。最新的年度报告显示,绝大多数外部收入来自美国,这突显了该公司主要以国内收入为基础。
近期发展主要集中在投资组合优化、临床可及性举措和资本管理。2025年,Cigna Healthcare 宣布了高管领导层变动,并继续强调旨在改善护理可及性的项目,包括数字肌肉骨骼护理和行为健康支持。该公司在资产负债表管理方面也保持活跃,包括管理层此前披露的债务要约活动。总体而言,Cigna 仍然是医疗保健领域的重要参与者,其规模、整合模式以及在美国这个高度监管、竞争激烈的市场中的强大地位为其提供了支持,在该市场中,可负担性、网络广度和护理协调是关键的差异化因素。